Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 5Terminated 4Unknown 1Suspended 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 2Plasma cell 1Other solid neoplasm 1Gynecologic 1CNS 1

Conditions

Thrombocytopenia 2Solid Tumor 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Glioblastoma 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × romiplostim × Clear all
NCT04671901 2025-05-28

A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated
2 enrolled 4 charts
Other solid neoplasm

Solid Tumor

NCT03622931 2021-02-08

TRACEII

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Phase 2 Terminated
21 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT01676961 2018-10-15

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

NYU Langone Health

Phase 2 Terminated
5 enrolled 4 charts
Classical hematologyPlasma cell

Multiple Myeloma, Thrombocytopenia

NCT02227576 2018-04-25

PLATUM

University Hospital, Lille

Phase 2 Terminated
20 enrolled
CNSClassical hematology

Glioblastoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡